Tuberculosis (TB) diagnosis is essential for disease identification and elimination. In 2016, Kenya listed gene pert as the first preferred test for TB diagnosis and identification of rifampicin resistance. This was informed by the need for a fast and efficient diagnosis of presumptive TB cases especially children and those living with HIV.
The study sought to assess the socio demographic and clinical characteristics of TB cases using geneX pert.
